AI Tumor Detection in Medical Imaging: What Failed, What It Cost, and What the Rules Say Now
Short answer. Computer vision for early tumor detection works in at least one large randomized trial (Sweden’s MASAI, 2026). It has also failed in documented, peer-reviewed ways: a mammography-CAD generation that added an estimated $400 million a year to U.S. screening costs without improving accuracy, a melanoma classifier fooled by surgical ink, radiologists dragged down … Read more
